Prediction of diagnosis of myeloid malignancy and MDS based on VAF or binary mutation profiles in 18 genes

Myeloid Malignancy & MDS Prediction Tool Version: 1.0

Myeloid Malignancy & MDS Prediction Tool Version: 1.0

The Myeloid Malignancy & MDS Prediction Tool was developed for research and educational purposes only. The tool must never be used in clinical decision making or to provide medical or diagnostic services. Individuals who use the tool do so at their own risk. For any real medical concerns, including decisions about medications and other treatments, users should always consult their physician or other qualified healthcare professional.

Welcome Page

VAF

Binary

Prediction of diagnosis of myeloid malignancy and MDS based on VAF or binary mutation profiles in 18 genes

The National Heart, Lung, and Blood Institute National MDS Natural History Study (NCT02775383) is a prospective cohort study enrolling cytopenic patients with suspected myelodysplastic syndromes (MDS) to evaluate factors associated with disease.

VAF Prediction Input

Prediction Output

Binary Prediction Input

Prediction Output